F. Perry Wilson, MD, MSCE, shares insights from a review of recent study results published in the New England Journal of Medicine examining duty-hours rules at 63 residency…
NEW YORK (Reuters Health) – After surgically induced remission of Crohn’s disease, treatment with mesalamine reduces the risk of relapse somewhat; sulfasalazine, however, has no apparent benefit, according…
NEW YORK (Reuters Health) – Intravitreal injection of clindamycin and dexamethasone to treat active ocular toxoplasmosis appears to be an alternative, and perhaps preferable, to classic treatment with…
NEW YORK (Reuters Health) – Among adult patients being treated for hematologic malignancies and who are at high risk for tumor lysis syndrome with hyperuricemia, intravenous rasburicase does…
NEW YORK (Reuters Health) – The 13-valent pneumococcal conjugate vaccine is as effective as the 7-valent vaccine, which it replaces, in protecting against disease caused by the original…
NEW YORK (Reuters Health) – The 2010 Update of the practice parameter on the diagnosis and management of anaphylaxis emphasizes education and self-administration of epinephrine for patients with…
NEW YORK (Reuters Health) – As long as eligibility criteria are strictly followed, it is safe to let “real world” patients undergoing percutaneous coronary intervention go home on…
NEW YORK (Reuters Health) – If recognized right away, most bile duct injuries related to laparoscopic cholecystectomy should be repaired quickly in a tertiary hepatobiliary center — within…
NEW YORK (Reuters Health) – The use of angiotensin blocking therapy before cardiac surgery is not associated with postoperative atrial fibrillation (AF), researchers report in the August American…
NEW YORK (Reuters Health) – In high-risk patients having percutaneous coronary intervention for ST-segment elevation acute myocardial infarction (STEMI), bivalirudin was more effective than unfractionated heparin plus a…
NEW YORK (Reuters Health) – Major surgery often leads to transient thyroid hormone derangements. When it does, short-duration T3 therapy has no apparent benefit, according to a new…
